Galangin expresses bactericidal activity against multiple-resistant bacteria: MRSA, Enterococcus spp. and Pseudomonas aeruginosa

FEMS Microbiology Letters

Volumn 240, Issue 1, 2004, Pages 111-116

  Pepeljnjak, Stjepan ^a   Kosalec, Ivan ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

3,5,7 Trihydroxyflavone; Bacteria; Enterococcus spp.; Flavonoids; Galangin; Pseudomonas aeruginosa; Resistance; Staphylococcus aureus

Indexed keywords

ANTIINFECTIVE AGENT; FLAVONOID; GALANGIN; GALANIN 3,5,7 TRIHYDROXYFLAVONE; GALANIN DERIVATIVE; PROPOLIS; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIOASSAY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENTEROCOCCUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SAMPLE; SPECIES; THIN LAYER CHROMATOGRAPHY;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MULTIPLE; ENTEROCOCCUS; FLAVONOIDS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

BACTERIA (MICROORGANISMS); ENTEROCOCCUS; NEGIBACTERIA; POSIBACTERIA; PROPOLIS; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 7044253545     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsle.2004.09.018     Document Type: Article

References (22)

1. J.-L. Vincent Nosocomial infections in adult intensive-care units Lancet 361 2003 2068 2077
2. J. Jeljaszewicz, G. Mlynarczyk, and A. Mlynarczyk Antibiotic resistance in Gram-positive cocci Int. J. Antimicro. Agents 16 2000 473 478
3. EARSS, European Antimicrobial Resistance Surveillance System, Available from: 〈 http://www.EARSS.rivm.nl 〉, February 2004
4. K. Hostettmann, O. Potterat, and Wolfender J.-L. The potential of higher plants as a source of new drugs Chimia 52 1998 10 17
5. S. Pepeljnjak, I. Kosalec, Z. Kalodjera, and D. Kuštrak Natural antimycotics from Croatian plants M.K. Rai D. Mares Plant-Derived Antimycotics, Current Trends and Future Prospects 2003 The Haworth Press New York, London, Oxford 49 81
6. S. Pepeljnjak, I. Jalšenjak, and D. Maysinger Growth inhibition of Bacillus subtilis and composition of various propolis extracts Pharmazie 37 1982 864 865
7. S. Pepepljnjak, I. Jalšenjak, and D. Maysinger Flavonoid content in propolis extracts and growth inhibition of Bacillus subtilis Pharmazie 40 1985 122 123
8. R. Hänsel, O. Sticher, and E. Steinegger Pharmakognosie- Phytopharmazie 1999 Springer-Verlag Berlin, Heidelberg, New York pp. 818-824
9. H. Tapiero, K.D. Tew, G. Nguyen Ba, and G. Mathé Polyphenols: do they play a role in the prevention of human pathologies? Biomed. Pharmacother. 56 2002 200 207
10. M.M. Cowan Plant products as antimicrobial agents Clin. Microbiol. Rev. 12 1999 564 582
11. I. Kosalec, M. Bakmaz, and S. Pepeljnjak Analysis of propolis from the continental and Adriatic regions of Croatia Acta Pharm. 53 2003 275 285
12. I. Kosalec, M. Bakmaz, S. Pepeljnjak, and S. Vladimir- Knežević Quantitative analysis of the flavonoids in raw propolis from northern Croatia Acta Pharm. 54 2004 65 72
13. G.A. Burdock Review of the biological properties and toxicity of bee propolis (propolis) Food Chem. Toxicol. 36 1998 347 363
14. Y.K. Park, M.H. Koo, J.A.S. Abreu, M. Ikegaki, J.A. Cury, and P.L. Rosalen Antimicrobial activity of propolis on oral microorganisms Current Microbiol. 36 1998 24 28
15. F.A Santos, E.M.A. Bastos, M. Uzeda, M.A.R Carvalho, L.M. Farias, E.S.A. Moreira, and F.C. Braga Antibacterial activity of Brazilian propolis and fractions against oral anaerobic bacteria J. Ethnopharmacol. 80 2002 1 7
16. K. Bosio, C. Avanzini, A. D'Avolio, O. Ozino, and D. Savoia In vitro activity of propolis against Streptococcus pyogenes Lett. Appl. Microbiol. 31 2000 174 177
17. C.-C. Chang, M.-H. Yang, H.-M. Wen, and J.-C. Chern Estimation of total flavonoid content by two complementary colorimetric methods J. Food Drug Anal. 10 2002 178 182
18. lNCCLS (National Committee for Clinical Laboratory Standards) (1999). Performance standards for antimicrobial susceptibility testing, In: 9th International Supplement, M100-S9
19. M.C. Marcucci, F. Ferreres, C. García-Viguera, V.S. Bankova, S.L. De Castro, A.P. Dantas, P.H.M. Valente, and N. Paulino Phenolic compounds from Brazilian propolis with pharmacological activities J. Ethnopharmacol. 74 2001 105 112
20. O.K. Mirzoeva, R.N. Grishanin, and P.C. Calder Antimicrobial action of propolis and some of its components: the effects of growth, membrane potential and motility of bacteria Microbiol. Res. 152 1997 239 246
21. N.B. Takaisi-Kikuni, and H. Schilcher Electron microscopic and microcalorimetric investigations of the possible mechanism of the antibacterial action of a defined propolis provenance Planta Med. 60 1994 222 227
22. M.I. Nieva Moreno, M.I. Isla, N.G. Cudmani, M.A. Vattuone, and A.R. Sampiero Screening of antimicrobial activity of Amaicha del Valle (Tucumán, Argentina) propolis J. Ethnopharmacol. 68 1999 97 102